GMED R&D to Revenue
Globus Medical, Inc. Class A Common Stock · R&D to Revenue
GMED R&D to Revenue
Latest reported4.60%period ending
GMED Quarterly R&D/Revenue (7.72% → 4.60%)
Latest values, visible window
High-resolution chart · PNG
GMED r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4.5999% | |
| 4.8049% | |
| 8.9446% | |
| 4.9499% | |
| 5.3605% | |
| 5.5276% | |
| 5.0827% | |
| 5.6544% | |
| 5.9867% | |
| 9.4398% | |
| 8.4751% | |
| 7.6449% | |
| 7.3203% | |
| 7.6194% | |
| 7.1064% | |
| 7.3583% | |
| 6.5978% | |
| 7.5524% | |
| 20.4071% | |
| 6.901% | |
| 6.1936% | |
| 6.5645% | |
| 6.5287% | |
| 6.6734% | |
| 26.4937% | |
| 8.0818% | |
| 7.3209% | |
| 7.3939% | |
| 8.094% | |
| 7.8296% | |
| 7.0216% | |
| 9.1748% | |
| 7.7995% | |
| 7.2753% | |
| 6.4834% | |
| 7.1746% | |
| 7.03% | |
| 6.8456% | |
| 8.9999% | |
| 7.5672% | |
| 7.7053% | |
| 7.2021% | |
| 6.8982% | |
| 6.7522% | |
| 6.7987% | |
| 6.5773% | |
| 6.5248% | |
| 6.9159% | |
| 6.7745% | |
| 6.5169% | |
| 5.569% | |
| 6.1276% | |
| 6.5761% | |
| 6.5198% | |
| 7.1895% | |
| 7.41% | |
| 7.2309% | |
| 7.1117% | |
| 6.5607% | |
| 7.0203% | |
| 7.0858% | |
| 7.716% |